Showing results (271-280 of 721) with videos related to
Sort By:
Pageof 73
Movement Disorders : Official Journal of the Movement Disorder Society|December 18, 2007
Clinical significance of RLSWayne A Hening, Richard P Allen, K Ray Chaudhuri, et al.Plos One|January 14, 2025
Wearable devices may aid the recognition of fluctuation-related pain in Parkinson's disease-An exploratory, cross-sectional analysis of two prospective observational studiesKatarina Rukavina, Juliet Staunton, Pavlos Zinzalias, et al.Acta Neurologica Scandinavica|September 12, 2015
Improvement of dyskinesias with L-dopa infusion in advanced Parkinson's diseaseJ Timpka, T Fox, K Fox, et al.Neurology|November 4, 2016
Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson diseaseGennaro Pagano, Sophie Molloy, Peter G Bain, et al.European Journal of Neurology|April 26, 2019
Extensive validation study of the Parkinson's Disease Composite ScaleP Martinez-Martin, F G Radicati, C Rodriguez Blazquez, et al.Journal of Neurology|August 18, 2020
Progression of sleep disturbances in Parkinson's disease: a 5-year longitudinal studyZheyu Xu, Kirstie N Anderson, Seyed Ehsan Saffari, et al.Plos One|November 13, 2012
Symptoms and quality of life in late stage Parkinson syndromes: a longitudinal community study of predictive factorsIrene J Higginson, Wei Gao, Tariq Zaffer Saleem, et al.Frontiers in Aging Neuroscience|December 12, 2025
Absence of the LRRK2 mutation in Emirati Parkinson's disease patients in contrast to other Arab populationsVinod Metta, Anjana Soorajkumar, Tom Loney, et al.Biomedicines|September 28, 2023
SARS-CoV-2 and Parkinson's Disease: A Review of Where We Are NowIro Boura, Mubasher A Qamar, Francesco Daddoveri, et al.Human Immunology|February 15, 2021
The role of immune-mediated alterations and disorders in ALS diseaseJoão Rodrigues Lima-Junior, David Sulzer, Cecilia S Lindestam Arlehamn, et al.Pageof 73